The global Anaesthesia information management systems market was surpassed at USD 464.7 billion in 2021 and is expected to hit around USD 774.82 billion by 2030, growing at a CAGR of 5.84% from 2022 to 2030
Factors including favorable government initiatives and campaigns, increasing adoption of next-generation AIMS technology, growing demand for improved ORMS, growing usage of healthcare information technology (HCIT) solutions, and funding for OR infrastructure are the major drivers of the global AIMS market.
Players in the market are engaged in the development of new products or strategic initiatives such as mergers & acquisitions in order to survive in the competitive market and meet consumer demand. Additionally, increasing investments by competitors act as an opportunity for market expansion. Investments in this industry are therefore anticipated to be profitable during the forecast period, resulting in technological breakthroughs. For instance, Provation recently purchased PENTAX Medical's endoscopic informatics and software portfolio. With more than 5,000 health systems, hospitals, surgery centers, and physician groups as clients, the acquisition aids Provation in expanding its customer.
The necessity for electronic health information has been highlighted by healthcare reform in recent years, which has increased interest in digital solutions. Additionally, the COVID-19 pandemic has ramped up industry growth by demonstrating the advantages of implementing electronic health information to assist advancements in patient care and scheduling. Value-based care systems are becoming more prevalent in a number of nations. This is increasing the demand for high-acuity IT solutions that promote clinical effectiveness and workflow, which in turn supports market expansion.
Technology advancements have transformed patient monitoring and treatment tools as well as the anesthetic record itself. Additionally, the paper Anaesthesia record is still in use, but an anesthetic information management system has taken its place in certain organizations. This demonstrates the growing need for Anaesthesia information management system adoption, which is expected to increase throughout the projection period.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 464.7 billion |
Revenue Forecast by 2030 | USD 774.82 billion |
Growth rate from 2022 to 2030 | CAGR of 5.84% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Solution type, end-use, region |
Companies Covered | Drägerwerk AG & Co. KGaA; GE Healthcare; Koninklijke Philips N.V.; Surgical Information Systems; Talis Clinical, LLC; Plexus Technology Group, LLC.; Provation; Oracle (Cerner); Allscripts Healthcare, LLC; Fukuda Denshi UK; iMDsoft |
Solution Type Insights
During the forecast period, it is anticipated that both software only and software with hardware and related components [IT support, Training Costs (Per Provider)] would increase at a CAGR of 5.7%. Due to the majority of hospitals and related end-users adopting advanced healthcare infrastructure, software with hardware and related components is also experiencing a relatively higher market volume. Installing such software along with the complete setup would give the user a cost-effective option of saving the high spending on capital equipment and related maintenance
An AIMS also increases patient safety by automatically transferring data from physiological monitoring and Anaesthesia equipment to an electronic anesthetic chart and by making evidence-based suggestions to reduce risks during surgery. These are a few of the perks that are anticipated to catch the attention of medical professionals and hospitals as these cutting-edge technologies would ultimately lead to reduced dose mistakes, thus contributing to market expansion during the forecast period.
The companies are establishing their market presence by implementing tactics such as partnerships with regional players to expand their reach and offer better solutions at a more affordable cost, which will eventually result in a rise in overall market growth throughout the forecast period. For instance, in February 2022, Provation appointed Gulf Medical Company, Ltd., as an exclusive collaborator in Saudi Arabia to sell and distribute its clinical productivity solution.
End-Use Insights
The next-generation technology AIMS software and its associated setup helps physicians make better decisions and manage hospital OR rooms and ASC settings altogether, which leads to faster adoption.
As the majority of hospitals handle significant fatal or chronic disease-related treatments, the need for advanced OR settings-which, in some cases, also necessitates specialized AIMS installations-leads to the hospital sector holding the biggest market share in 2021, at over 80%, and is anticipated to hold that position throughout the forecast period.
The hospitals are an essential component of healthcare and serve as the main source of sales for the whole sector, which supports technology and development not just in nations like the U.S. but also generally in areas like Europe. Due to this, a few companies spend on techniques like sales & advertising, and marketing to sell their products at the majority of hospitals. In February 2022, Plexus Technology Group, LLC proclaimed that its Anaesthesia Touch has grabbed a critical breakthrough by being deployed into over 1,000 hospital systems countrywide.
During the forecast period, the ASC segment is anticipated to develop more quickly than other market segments. The growth in costs, which also adds to the fact that a specific set of people can afford the essential treatment, including surgical procedures, is a major problem confronting the healthcare sector. Additionally, ASCs provide the patient defensive measures and are preferable settings for elective surgery. As a result, healthcare providers have been obliged to switch to more advanced settings, one of which includes AIMS as a component to find new ways to make such healthcare more affordable without compromising quality. Consequently, since ASCs have shown to be a good solution in this scenario, add to the category with quicker growth.
Regional Insights
Due to improved awareness of Anaesthesia information management systems' effectiveness, increased emphasis on anesthetic dosage, and complete data management, along with growing demand for knowledge-based medical equipment, North America held the largest sales share of almost 64%in 2021.
The growing number of initiatives to promote healthcare IT and the existence of healthcare programs are just a few of the major reasons the region is anticipated to witness expansion. Additionally, it is anticipated that the region's market participants' strategic moves and strong R&D investment will boost the North American market. For instance, Surgical Information Systems relocated its corporate headquarters to the Avalon neighborhood in March 2022. The new workplace is designed to be a cutting-edge hub for collaboration and meetings that supports flexible working hours.
The Asia Pacific market is presumed to witness the fastest growth. The market is fueled by a growing pool of patient populations with chronic conditions that necessitate surgical treatments and a quickly developing healthcare infrastructure. The National Digital Health Mission, a full digital health ecosystem, was unveiled by the Indian government in August 2020. Such programs can aid in the expansion of the region’s market.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Anaesthesia Information Management Systems Market
5.1. COVID-19 Landscape: Anaesthesia Information Management Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Anaesthesia Information Management Systems Market, By Solution Type
8.1. Anaesthesia Information Management Systems Market, by Solution Type, 2022-2030
8.1.1. Software Only
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Software with Hardware and related components
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Anaesthesia Information Management Systems Market, By End-Use
9.1. Anaesthesia Information Management Systems Market, by End-Use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory surgical centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Anaesthesia Information Management Systems Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.1.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.2.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Solution Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 11. Company Profiles
11.1. Drägerwerk AG & Co. KGaA
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. GE Healthcare
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Koninklijke Philips N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Surgical Information Systems
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Talis Clinical, LLC
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Plexus Technology Group, LLC.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Provation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Oracle (Cerner)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Allscripts Healthcare, LLC
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Fukuda Denshi UK
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms